How to improve care for patients with RA and comorbidities von Radner, Helga

Volltext

Remission in rheumatoid arthritis: benefit over low disease activity in patient-reported outcomes and costs von Radner, Helga, Smolen, Josef S, Aletaha, Daniel

Volltext

Performance of the 2010 ACR/EULAR classification criteria for rheumatoid arthritis: a systematic literature review von Radner, Helga, Neogi, Tuhina, Smolen, Josef S, Aletaha, Daniel

Volltext

Viewpoint: how to measure comorbidities in patients with rheumatoid arthritis – clinical and academic value von Radner, Helga

Volltext

Heterologous vector versus homologous mRNA COVID-19 booster vaccination in non-seroconverted immunosuppressed patients: a randomized controlled trial von Mrak, Daniel, Sieghart, Daniela, Simader, Elisabeth, Tobudic, Selma, Radner, Helga, Mandl, Peter, Göschl, Lisa, Koblischke, Maximilian, Hommer, Nikolaus, Wagner, Angelika, Mayer, Margareta, Schubert, Lorenz, Hartl, Lukas, Kozbial, Karin, Hofer, Philipp, Kartnig, Felix, Hummel, Thomas, Kerschbaumer, Andreas, Deimel, Thomas, Puchner, Antonia, Gudipati, Venugopal, Thalhammer, Renate, Munda, Petra, Uyanik-Ünal, Keziban, Zuckermann, Andreas, Novacek, Gottfried, Reiberger, Thomas, Garner-Spitzer, Erika, Reindl-Schwaighofer, Roman, Kain, Renate, Winkler, Stefan, Smolen, Josef S., Stiasny, Karin, Fischer, Gottfried F., Perkmann, Thomas, Haslacher, Helmuth, Zeitlinger, Markus, Wiedermann, Ursula, Aberle, Judith H., Aletaha, Daniel, Heinz, Leonhard X., Bonelli, Michael

Volltext

The impact of multimorbidity status on treatment response in rheumatoid arthritis patients initiating disease-modifying anti-rheumatic drugs von Radner, Helga, Yoshida, Kazuki, Frits, Michelle, Iannaccone, Christine, Shadick, Nancy A, Weinblatt, Michael, Smolen, Josef S, Solomon, Daniel H

Volltext

Serological changes in the course of traditional and biological disease modifying therapy of rheumatoid arthritis von Böhler, Christoph, Radner, Helga, Smolen, Josef S, Aletaha, Daniel

Volltext

The use and diagnostic value of testing myositis-specific and myositis-associated autoantibodies by line immuno-assay: a retrospective study von Lackner, Angelika, Tiefenthaler, Viktoria, Mirzayeva, Jalia, Posch, Florian, Rossmann, Christopher, Kastrati, Kastriot, Radner, Helga, Demel, Ulrike, Gretler, Judith, Stotz, Michael, Graninger, Winfried B, Stradner, Martin H

Volltext

Low rates of biologic-free clinical disease activity index remission maintenance after biologic disease-modifying anti-rheumatic drug discontinuation while in remission in a Japane... von Yoshida, Kazuki, Kishimoto, Mitsumasa, Radner, Helga, Matsui, Kazuo, Okada, Masato, Saeki, Yukihiko, Solomon, Daniel H, Tohma, Shigeto

Volltext

Multimorbidity in rheumatic conditions von Radner, Helga

Volltext

Anti-TNF in rheumatoid arthritis: an overview von Radner, Helga, Aletaha, Daniel

Volltext

What benefit–risk trade-offs are acceptable to rheumatoid arthritis patients during treatment selection? Evidence from a multicountry choice experiment von Alten, Rieke, Nieto-Gonzalez, Juan Carlos, Jacques, Peggy, Montecucco, Carlomaurizio, Moots, Robert, Radner, Helga, Vonkeman, Harald E, Heidenreich, Sebastian, Whichello, Chiara, Krucien, Nicolas, Van Beneden, Katrien

Volltext

Value of self-performed joint counts in rheumatoid arthritis patients near remission von Radner, Helga, Grisar, Johannes, Smolen, Josef S, Stamm, Tanja, Aletaha, Daniel

Volltext

I133Harmonizing Data Collection for Observational Studies in Adult Inflammatory Arthritis: A European Initiative von Radner, Helga

Volltext

The accelerated waning of immunity and reduced effect of booster in patients treated with bDMARD and tsDMARD after SARS-CoV-2 mRNA vaccination von Tobudic, Selma, Simader, Elisabeth, Deimel, Thomas, Straub, Jennifer, Kartnig, Felix, Heinz, Leonhard X, Mandl, Peter, Haslacher, Helmuth, Perkmann, Thomas, Schneider, Lisa, Nothnagl, Thomas, Radner, Helga, Winkler, Florian, Burgmann, Heinz, Stiasny, Karin, Novacek, Gottfried, Reinisch, Walter, Aletaha, Daniel, Winkler, Stefan, Blüml, Stephan

Volltext

Predictors of successful discontinuation of biologic and targeted synthetic DMARDs in patients with rheumatoid arthritis in remission or low disease activity: a systematic literatu... von Schlager, Lukas, Loiskandl, Michaela, Aletaha, Daniel, Radner, Helga

Volltext

P160 Drug survival in SLE: real world data from the vienna lupus cohort von Mrak, Daniel, Pacher, Julia, Reischmann, Lena, Weber, Peter, Kastrati, Kastriot, Heinz, Leonhard X, Aletaha, Daniel, Bonelli, Michael Markus, Lechner-Radner, Helga

Volltext

Incidence and Prevalence of Cardiovascular Risk Factors Among Patients With Rheumatoid Arthritis, Psoriasis, or Psoriatic Arthritis von Radner, Helga, Lesperance, Tamara, Accortt, Neil A., Solomon, Daniel H.

Volltext

Discrepancies between patients and physicians in their perceptions of rheumatoid arthritis disease activity von Studenic, Paul, Radner, Helga, Smolen, Josef S., Aletaha, Daniel

Volltext

Do rheumatologists know best? An outcomes study of inconsistent users of disease-modifying anti-rheumatic drugs von Mjaavatten, Maria D., MD, PhD, Radner, Helga, MD, Yoshida, Kazuki, MD, MPH, Shadick, Nancy A., MD, MPH, Frits, Michelle L., BA, Iannaccone, Christine K., MPH, Kvien, Tore K., MD, PhD, Weinblatt, Michael E., MD, MPH, Solomon, Daniel H., MD, MPH

Volltext